Target Price | $5.10 |
Price | $2.15 |
Potential |
137.21%
register free of charge
|
Number of Estimates | 4 |
4 Analysts have issued a price target Spero Therapeutics, Inc. 2026 .
The average Spero Therapeutics, Inc. target price is $5.10.
This is
137.21%
register free of charge
$5.25
144.19%
register free of charge
$5.05
134.88%
register free of charge
|
|
A rating was issued by 7 analysts: 0 Analysts recommend Spero Therapeutics, Inc. to buy, 4 to hold and 3 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Spero Therapeutics, Inc. stock has an average upside potential 2026 of
137.21%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 47.98 | 20.50 |
53.77% | 57.27% | |
Net Margin | -142.91% | -232.03% |
750.22% | 62.36% |
4 Analysts have issued a sales forecast Spero Therapeutics, Inc. 2025 . The average Spero Therapeutics, Inc. sales estimate is
This results in the following potential growth metrics:
5 Spero Therapeutics, Inc. Analysts have issued a net profit forecast 2025. The average Spero Therapeutics, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -1.27 | -0.85 |
395.35% | 33.07% | |
P/E | negative | |
EV/Sales | 4.38 |
5 Analysts have issued a Spero Therapeutics, Inc. forecast for earnings per share. The average Spero Therapeutics, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Spero Therapeutics, Inc....
Analyst | Rating | Action | Date |
---|---|---|---|
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jan 30 2025 |
Evercore ISI Group |
Locked
➜
Locked
|
Locked | Dec 20 2024 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Dec 02 2024 |
TD Cowen |
Locked
➜
Locked
|
Locked | Nov 18 2024 |
Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | Nov 15 2024 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 04 2024 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Oct 03 2024 |
Analyst Rating | Date |
---|---|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jan 30 2025 |
Locked
Evercore ISI Group:
Locked
➜
Locked
|
Dec 20 2024 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Dec 02 2024 |
Locked
TD Cowen:
Locked
➜
Locked
|
Nov 18 2024 |
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
Nov 15 2024 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 04 2024 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Oct 03 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.